Breaking Down Kidney Disease: From Guidelines to Prognostic Profiling

News
Video

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Sydney Jennings
August 28th 2025
Article
Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
August 28th 2025
Podcast
FDA Clears First Over-The-Counter CGM for Weight Management From Signos / image credit ©lukszczepanski/stock.adobe.com

Signos Wins Clearance for First Over-The-Counter CGM for Weight Management

Grace Halsey
August 28th 2025
Article
Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
August 28th 2025
Podcast
Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose / image credit: ©New Africa/AdobeStock

Excess Intake of Ultraprocessed Foods Tied to Higher Cardiometabolic Risk: Daily Dose

Sydney Jennings
August 28th 2025
Article
Atumelnant for Congenital Adrenal Hyperplasia Agent Granted FDA Orphan Drug Designation / ©pikovit/stock.adobe.com

Atumelnant for Congenital Adrenal Hyperplasia Agent Granted FDA Orphan Drug Designation

Grace Halsey
August 28th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.